Contract HHSO100201500013C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · September 23, 2022
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 23, 2022 for an undisclosed amount of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 23, 2024. If all options are exercised, the contract could reach $44.44 million.
Contract details
- PIID
- HHSO100201500013C
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 23, 2022
- Latest action
- July 23, 2024
Description
DE-OBLIGATE FISCAL YEAR 2024 CANCELING FUNDS.
Modification timeline
-
July 23, 2024Mod P00011 · Funding Only Action$33.14M
-
September 23, 2022Mod P00009 · Supplemental Agreement For Work Within ScopeREGENERON- ADD HHSAR CLAUSE AT 352.232-71, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS.$34.57M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201500013C?
Contract HHSO100201500013C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on September 23, 2022 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 1 time since the base award.
Who won contract HHSO100201500013C?
Regeneron Pharmaceuticals Inc won contract HHSO100201500013C from Department Of Health And Human Services.
How much is contract HHSO100201500013C worth?
Contract HHSO100201500013C has obligated $0 to date but carries a potential ceiling of $44.44 million if fully funded and all options are exercised.